+Advanced Search
Home > Archive>Volume 27, Issue 2, 2017 >86-92. DOI:10.3969.j.issn.1671-7856.2017.02.016
PDF HTML XML Export Cite reminder
Research progress of exosomes in tumor diagnosis and treatment
CSTR:
[cstr]
Author:
  • Article
    • | |
  • Metrics
    • |
  • Reference [65]
    • | | | |
  • Comments
    Abstract:

    Exosomes have a size of 30-100 nm and membrane-bound nanovesicles, which is widely present in nearly all human body fluids, such as serum, saliva and urine, etc. Exosomes contain multiple proteins, nucleotides, and even viruses, and play an important role in the substance exchange and information transmission between cells. Recently, research found that genetic materials secreted from exosomes such as mRNA and miRNA were directly derived from their parent tumor cells, and they can directly effect on the receptor cells. Therefore, exosomes may become a new target for diagnosis and treatment of cancer. In this review, we described exosomes as a marker in early diagnosis of cancer, and its applications in cancer therapy.

    Reference
    [1] Wickman G, Julian L, Olson M. How apoptotic cells aid in the removal of their own cold dead bodies[J]. Cell Death Differ, 2012, 19(5):735-742.
    [2] Heijnen HF, Schiel AE, Fijnheer R, et al. Activated platelets release two types of membrane vesicles:microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alphagranules[J]. Blood, 1999; 94(11):3791-3799.
    [3] Trams EG, Lauter CJ, Norman Salem J, et al. Exfoliation of membrane ecto-enzymes in the form of micro-vesicles[J]. Biochim Biophys Acta (BBA)-Biomembranes, 1981, 645(1):63-70.
    [4] Thery C, Ostrowski M, Segura E. Membrane vesicles as conveyors of immune responses[J]. Nat Rev Immunol, 2009, 9(8):581-593.
    [5] Pan BT, Johnstone RM. Fate of the transferrin receptor during maturation of sheep reticulocytes in vitro:selective externalization of the receptor[J]. Cell, 1983, 33(3):967-978.
    [6] Lasser C, Alikhani VS, Ekstrom K, et al. Human saliva, plasma and breast milk exosomes contain RNA:uptake by macrophages[J]. J Transl Med, 2011, 9:9.
    [7] Street JM, Barran PE, Mackay CL, et al. Identification and proteomic profiling of exosomes in human cerebrospinal fluid[J]. J Transl Med, 2012; 10:5.
    [8] Pisitkun T, Shen RF and Knepper MA. Identification and proteomic profiling of exosomes in human urine[J]. Proc Natl Acad Sci USA, 2004, 101(36):13368-13373.
    [9] Vojtech L, Woo S, Hughes S, et al. Exosomes in human semen carry a distinctive repertoire of small non-coding RNAs with potential regulatory functions[J]. Nucleic Acids Res, 2014:42(11):7290-304.
    [10] Yu S, Cao H, Shen B, et al. Tumor-derived exosomes in cancer progression and treatment failure[J]. Oncotarget, 2015, 6(35):37151-37168.
    [11] Mathivanan S, Fahner CJ, Reid GE et al. ExoCarta 2012:database of exosomal proteins, RNA and lipids[J]. Nucleic Acids Res, 2012, 40(D1):D1241-D1244.
    [12] Denzer K, Kleijmeer MJ, Heijnen HF, et al. Exosome:from internal vesicle of the multivesicular body to intercellular signaling device[J]. J Cell Sci, 2000, 113(19):3365-3374.
    [13] Liang B, Peng P, Chen S, et al. Characterization and proteomic analysis of ovarian cancer-derived exosomes[J]. J Proteomics, 2013, 80:171-182.
    [14] Yuyama K, Sun H, Mitsutake S, et al. Sphingolipid-modulated exosome secretion promotes clearance of amyloid-β by microglia[J]. J Biol Chem, 2012, 287(14):10977-10989.
    [15] Valadi H, Ekstrom K, Bossios A, et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells[J]. Nat Cell Biol, 2007, 9(6):654-659.
    [16] Li M, Zeringer E, Barta T, et al. Analysis of the RNA content of the exosomes derived from blood serum and urine and its potential as biomarkers[J]. Philos Transact Royal Soc B:Biol Sci, 2014, 369(1652):20130502.
    [17] Tanaka Y, Kamohara H, Kinoshita K, et al. Clinical impact of serum exosomal microRNA-21 as a clinical biomarker in human esophageal squamous cell carcinoma[J]. Cancer, 2013, 119(6):1159-1167.
    [18] Keller S, Sanderson MP, Stoeck A et al. Exosomes:from biogenesis and secretion to biological function[J]. Immunol Lett, 2006, 107(2):102-108.
    [19] Park JE, Tan HS, Datta A, et al. Hypoxic tumor cell modulates its microenvironment to enhance angiogenic and metastatic potential by secretion of proteins and exosomes[J]. Mol Cell Proteomics, 2010, 9(6):1085-1099.
    [20] Savina A, Furlan M, Vidal M, et al. Exosome release is regulated by a calcium-dependent mechanism in K562 cells[J]. J Biol Chem, 2003, 278(22):20083-20090.
    [21] Lespagnol A, Duflaut D, Beekman C, et al. Exosome secretion, including the DNA damage-induced p53-dependent secretory pathway, is severely compromised in TSAP6/Steap3-null mice[J]. Cell Death Differ, 2008, 15(11):1723-1733.
    [22] Trajkovic K, Hsu C, Chiantia S, et al. Ceramide triggers budding of exosome vesicles into multivesicular endosomes[J]. Science, 2008, 319(5867):1244-1247.
    [23] Ostrowski M, Carmo NB, Krumeich S, et al. Rab27a and Rab27b control different steps of the exosome secretion pathway[J]. Nat Cell Biol, 2010, 12(1):19-30.
    [24] Thery C, Amigorena S, Raposo G, et al. Isolation and characterization of exosomes from cell culture supernatants and biological fluids[M]. Curr Protoc Cell Biol, 2006, Chapter 3:Unit 3.22.
    [25] Zlotogorski-Hurvitz A, Dayan D, Chaushu G, et al. Human saliva-derived exosomes:comparing methods of isolation[J]. J Histochem Cytochem, 2015, 63(3):181-189.
    [26] Logozzi M, De Milito A, Lugini L, et al. High levels of exosomes expressing CD63 and caveolin-1 in plasma of melanoma patients[J]. PloS One, 2009, 4(4):e5219.
    [27] Hong CS, Muller L, Boyiadzis M, et al. Isolation and characterization of CD34+ blast-derived exosomes in acute myeloid leukemia[J]. PLoS One, 2014, 9(8):e103310.
    [28] Morelli AE, Larregina AT, Shufesky WJ, et al. Endocytosis, intracellular sorting, and processing of exosomes by dendritic cells[J]. Blood, 2004, 104(10):3257-3266.
    [29] Thery C, Zitvogel L, Amigorena S. Exosomes:composition, biogenesis and function[J]. Nat Rev Immunol, 2002, 2(8):569-579.
    [30] Hannafon BN, Ding WQ. Intercellular communication by exosome-derived microRNAs in cancer[J]. Int J Mol Sci, 2013, 14(7):14240-14269.
    [31] Cossetti C, Lugini L, Astrologo L, et al. Soma-to-germline transmission of RNA in mice xenografted with human tumour cells:possible transport by exosomes[J]. PloS One, 2014; 9(7):e101629.
    [32] Kahlert C, Kalluri R. Exosomes in tumor microenvironment influence cancer progression and metastasis[J]. J Mol Med (Berl), 2013, 91(4):431-437.
    [33] Madhavan B, Yue S, Galli U, et al. Combined evaluation of a panel of protein and miRNA serum-exosome biomarkers for pancreatic cancer diagnosis increases sensitivity and specificity[J]. Int J Cancer, 2015, 136(11):2616-2627.
    [34] Ogata-Kawata H, Izumiya M, Kurioka D, et al. Circulating exosomal microRNAs as biomarkers of colon cancer[J]. PLoS One, 2014, 9(4):e92921.
    [35] Melo SA, Luecke LB, Kahlert C, et al. Glypican-1 identifies cancer exosomes and detects early pancreatic cancer[J]. Nature, 2015, 523(7559):177-182.
    [36] Zhou YG, Mohamadi RM, Poudineh M, et al. Interrogating circulating microsomes and exosomes using metal nanoparticles[J]. Small (Weinheim an der Bergstrasse, Germany), 2016, 12(6):727-32.
    [37] Nguyen DX, Bos PD, Massague J. Metastasis:from dissemination to organ-specific colonization[J]. Nat Rev Cancer, 2009, 9(4):274-284.
    [38] Hong BS, Cho J-H, Kim H, et al. Colorectal cancer cell-derived microvesicles are enriched in cell cycle-related mRNAs that promote proliferation of endothelial cells[J]. BMC Genomics, 2009, 10(1):556.
    [39] Kogure T, Lin WL, Yan IK, et al. Intercellular nanovesicle-mediated microRNA transfer:A mechanism of environmental modulation of hepatocellular cancer cell growth[J]. Hepatology, 2011, 54(4):1237-1248.
    [40] Zhu W, Huang L, Li Y, et al. Exosomes derived from human bone marrow mesenchymal stem cells promote tumor growth in vivo[J]. Cancer Lett, 2012, 315(1):28-37.
    [41] Atay S, Banskota S, Crow J, et al. Oncogenic KIT-containing exosomes increase gastrointestinal stromal tumor cell invasion[J]. Proc Natl Acad Sci U S A, 2014, 111(2):711-716.
    [42] Aga M, Bentz GL, Raffa S, et al. Exosomal HIF1alpha supports invasive potential of nasopharyngeal carcinoma-associated LMP1-positive exosomes[J]. Onl. Oncogenic Her2 delta 16 suppresses mir-15a/6 and deregulates Bcl-2 to promote endocrine resistance of breast tumors[J]. Carcinogenesis, 2010, 31(12):2049-2057.
    [67] Sebio A, Pare L, Paez D, et al. The Lcs6 polymorphism in the binding site of let-7 microRNA to the KRAS 3'-untranslated region:its role in the efficacy of anti-EGFR-based therapy in metastatic colorectal cancer patients[J]. Pharmacogenet Genomics, 2013, 23(3):142-147.
    [68] Holleman A, Chung I, Olsen R R, et al. miR-135a contributes to paclitaxel resistance in tumor cells both in vitro and in vivo[J]. Oncogene, 2011, 30(43):4386-4398.
    [69] Han S Y, Zhao M B, Zhuang G B, et al. Marsdenia tenacissima extract restored gefitinib sensitivity in resistant non-small cell lung cancer cells[J]. Lung Cancer, 2012, 75(1):30-37.
    [70] Putz U, Howitt J, Doan A, et al. The tumor suppressor PTEN is exported in exosomes and has phosphatase activity in recipient cells[J]. Sci Signaling, 2012, 5(243):ra70.
    [71] Mizrak A, Bolukbasi MF, Ozdener GB, et al. Genetically engineered microvesicles carrying suicide mRNA/protein inhibit schwannoma tumor growth[J]. Mol Ther, 2013, 21(1):101-108.
    [72] Ohno S, Takanashi M, Sudo K, et al. Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells[J]. Mol Ther, 2013, 21(1):185-191.
    [73] Lentz MR. Continuous whole blood UltraPheresis procedure in patients with metastatic cancer[J]. J Biol Response Mod,1989, 8(5):511-527.
    [74] Marleau AM, Chen C-S, Joyce JA et al. Exosome removal as a therapeutic adjuvant in cancer[J]. J Transl Med, 2012, 10(1):134.
    [75] Federici C, Petrucci F, Caimi S, et al. Exosome release and low pH belong to a framework of resistance of human melanoma cells to cisplatin[J]. PloS One, 2014, 9(2):e88193.
    [76] Lai RC, Yeo RW, Tan KH, et al. Exosomes for drug delivery-a novel application for the mesenchymal stem cell[J]. Biotechnol Adv, 2013, 31(5):543-551.. Lancet, 2002, 360(9329):295-305.
    [54] Escudier B, Dorval T, Chaput N, et al. Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes:results of thefirst phase I clinical trial[J]. J Transl Med, 2005, 3(1):10.
    [55] Viaud S, Terme M, Flament C, et al. Dendritic cell-derived exosomes promote natural killer cell activation and proliferation:a role for NKG2D ligands and IL-15Ralpha[J]. PLoS One, 2009, 4(3):e4942.
    [56] Morse MA, Garst J, Osada T, et al. A phase I study of dexosome immunotherapy in patients with advanced nonsmall cell lung cancer[J]. J Transl Med, 2005, 3(1):9.
    [57] Dai S, Wei D, Wu Z, et al. Phase I clinical trial of autologous ascites-derived exosomes combined with GM-CSF for colorectal cancer[J]. Mol Ther, 2008, 16(4):782-790.
    [58] Filipazzi P, Burdek M, Villa A, et al. Recent advances on the role of tumor exosomes in immunosuppression and disease progression[J]. Semin Cancer Biol (Elsevier), 2012, 22(4):342-349.
    [59] Yang C, Kim SH, Bianco NR, et al. Tumor-derived exosomes confer antigen-specific immunosuppression in a murine delayed-type hypersensitivity model[J]. PLoS One, 2011, 6(8):e22517.
    [60] Clayton A, Tabi Z. Exosomes and the MICA-NKG2D system in cancer[J]. Blood Cells Mol Dis, 2005, 34(3):206-213.
    [61] Clayton A, Mitchell JP, Court J, et al. Human tumor-derived exosomes down-modulate NKG2D expression[J]. J Immunol, 2008, 180(11):7249-7258.
    [62] Gastpar R, Gehrmann M, Bausero MA, et al. Heat shock protein 70 surface-positive tumor exosomes stimulate migratory and cytolytic activity of natural killer cells[J]. Cancer Res, 2005, 65(12):5238-5247.
    [63] 张敏, 张晨光, 丁卫. 外泌体及其在肿瘤诊断中的意义[J]. 生理科学进展, 2014, 45(5):372-378.
    [64] Tian Y, Li S, Song J, et al. A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy[J]. Biomaterials, 2014, 35(7):2383-2390.
    [65] Jeon HM, Sohn YW, Oh SY, et al. Id4 imparts chemoresistance and cancer stemness to glioma cells by derepressing mir-9-mediated suppression of Sox2[J]. Cancer Res, 2011, 71(9):3410-3421.
    [66] Cittelly DM, Das PM, Salvo VA, et a
    Related
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation

Copy
Share
Article Metrics
  • Abstract:2414
  • PDF: 4512
  • HTML: 0
  • Cited by: 0
History
  • Revised:July 25,2016
  • Online: March 09,2017
Article QR Code
You are the first3034807 Visitors
® 2025 All Rights Reserved
Address：5 Panjiayuan Nanli, Chaoyang District, Beijing 100021, China Postcode： Phone：86-10-67779337 E-mail:bjb@cnilas.org
Supported by:Beijing E-Tiller Technology Development Co., Ltd.